LUCA Biologics

LUCA Biologics is a biotechnology company developing a new class of living medicines targeting the vaginal microbiome to impact reproductive and urogenital health. Emerging from the lab of Dr. Jacques Ravel, a leading scientist in the vaginal microbiome division of the NIH's Human Microbiome Project, the company has built a metagenomic and metatranscriptomic platform to identify and validate strains to modulate the vaginal and urogenital microbiome.